{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:30:49Z","timestamp":1787002249258,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T00:00:00Z","timestamp":1339632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1038\/jhg.2012.68","type":"journal-article","created":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T02:23:36Z","timestamp":1339640616000},"page":"575-579","source":"Crossref","is-referenced-by-count":26,"title":["High-throughput screening identified disease-causing mutants and functional variants of \u03b1-galactosidase A gene in Japanese male hemodialysis patients"],"prefix":"10.1038","volume":"57","author":[{"given":"Kent","family":"Doi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisei","family":"Noiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Ishizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousuke","family":"Negishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tsukimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadayasu","family":"Togawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,14]]},"reference":[{"key":"BFjhg201268_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"RO Brady","year":"1967","unstructured":"Brady, R.O., Gal, A.E., Bradley, R.M., Martensson, E., Warshaw, A.L., Laster, L. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N. Engl. J. Med. 276, 1163\u20131167 (1967).","journal-title":"N. Engl. J. Med."},{"key":"BFjhg201268_CR2","first-page":"3373","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick, R.J., Ioannou, Y., Eng, C.M. in The Metabolic and Molecular Bases of Inherited Disease. Scriver C.R., Beaudet A.L., Sly W.S. & Valle D. (eds). 3373\u20133374 (McGraw-Hill: New York, 2001)."},{"key":"BFjhg201268_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"MH Branton","year":"2002","unstructured":"Branton, M.H., Schiffmann, R., Sabnis, S.G., Murray, G.J., Quirk, J.M., Altarescu, G. et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine 81, 122\u2013138 (2002).","journal-title":"Medicine"},{"key":"BFjhg201268_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao, S., Takenaka, T., Maeda, M., Kodama, C., Tanaka, A., Tahara, M. et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N. Engl. J. Med. 333, 288\u2013293 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFjhg201268_CR5","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/S0272-6386(04)01094-7","volume":"44","author":"D Rosenthal","year":"2004","unstructured":"Rosenthal, D., Lien, Y.H., Lager, D., Lai, L.W., Shang, S., Leung, N. et al. A novel alpha-galactosidase a mutant (M42L) identified in a renal variant of Fabry disease. Am. J. Kidney Dis. 44, e85\u2013e89 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFjhg201268_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJM199102073240607","volume":"324","author":"W von Scheidt","year":"1991","unstructured":"von Scheidt, W., Eng, C.M., Fitzmaurice, T.F., Erdmann, E., H\u00fcbner, G., Olsen, E.G. et al. An atypical variant of Fabry's disease with manifestations confined to the myocardium. N. Engl. J. Med. 324, 395\u2013399 (1991).","journal-title":"N. Engl. J. Med."},{"key":"BFjhg201268_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/hrt.2006.104026","volume":"94","author":"DA Hughes","year":"2008","unstructured":"Hughes, D.A., Elliott, P.M., Shah, J., Zuckerman, J., Coghlan, G., Brookes, J. et al. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Heart 94, 153\u2013158 (2008).","journal-title":"Heart"},{"key":"BFjhg201268_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/mus.10497","volume":"28","author":"R Schiffmann","year":"2003","unstructured":"Schiffmann, R., Floeter, M.K., Dambrosia, J.M., Gupta, S., Moore, D.F., Sharabi, Y. et al. Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve. 28, 703\u2013710 (2003).","journal-title":"Muscle Nerve."},{"key":"BFjhg201268_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ndt\/gfi152","volume":"21","author":"R Schiffmann","year":"2006","unstructured":"Schiffmann, R., Ries, M., Timmons, M., Flaherty, J.T., Brady, R.O. Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting. Nephrol. Dial. Transplant. 21, 345\u2013354 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFjhg201268_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","volume":"146","author":"M Banikazemi","year":"2007","unstructured":"Banikazemi, M., Bultas, J., Waldek, S., Wilcox, W.R., Whitley, C.B., McDonald, M. et al. Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann. Intern. Med. 146, 77\u201386 (2007).","journal-title":"Ann. Intern. Med."},{"key":"BFjhg201268_CR11","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann, R., Kopp, J.B., Austin, H.A., Sabnis, S., Moore, D.F., Weibel, T. et al. Enzyme Replacement Therapy in Fabry Disease. JAMA 285, 2743\u20132749 (2001).","journal-title":"JAMA"},{"key":"BFjhg201268_CR12","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1681\/ASN.2008080870","volume":"20","author":"M West","year":"2009","unstructured":"West, M., Nicholls, K., Mehta, A., Clarke, J.T., Steiner, R., Beck, M. et al. Agalsidase alfa and kidney dysfunction in Fabry disease. J. Am. Soc. Nephrol. 20, 1132\u20131139 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFjhg201268_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/jmg.2009.072116","volume":"47","author":"GE Linthorst","year":"2010","unstructured":"Linthorst, G.E., Bouwman, M.G., Wijburg, F.A., Aerts, J.M., Poorthuis, B.J., Hollak, C.E. Screening for Fabry disease in high-risk populations: a systematic review. J. Med. Genet. 47, 217\u2013222 (2010).","journal-title":"J. Med. Genet."},{"key":"BFjhg201268_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1159\/000250968","volume":"30","author":"H Fujii","year":"2009","unstructured":"Fujii, H., Kono, K., Goto, S., Onishi, T., Kawai, H., Hirata, K. et al. Prevalence and cardiovascular features of Japanese hemodialysis patients with Fabry disease. Am. J. Nephrol. 30, 527\u2013535 (2009).","journal-title":"Am. J. Nephrol."},{"key":"BFjhg201268_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5414\/CNP64281","volume":"64","author":"M Tanaka","year":"2005","unstructured":"Tanaka, M., Ohashi, T., Kobayashi, M., Eto, Y., Miyamura, N., Nishida, K. et al. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients. Clin. Nephrol. 64, 281\u2013287 (2005).","journal-title":"Clin. Nephrol."},{"key":"BFjhg201268_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s10157-005-0369-4","volume":"9","author":"M Ichinose","year":"2005","unstructured":"Ichinose, M., Nakayama, M., Ohashi, T., Utsunomiya, Y., Kobayashi, M., Eto, Y. Significance of screening for Fabry disease among male dialysis patients. Clin. Exp. Nephrol. 9, 228\u2013232 (2005).","journal-title":"Clin. Exp. Nephrol."},{"key":"BFjhg201268_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao, S., Kodama, C., Takenaka, T., Tanaka, A., Yasumoto, Y., Yoshida, A. et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u2018renal variant\u2019 phenotype. Kidney Int. 64, 801\u2013807 (2003).","journal-title":"Kidney Int."},{"key":"BFjhg201268_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","volume":"112","author":"JS Mayes","year":"1981","unstructured":"Mayes, J.S., Scheerer, J.B., Sifers, R.N., Donaldson, M.L. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease. Clin. Chem. Acta. 112, 247\u2013251 (1981).","journal-title":"Clin. Chem. Acta."},{"key":"BFjhg201268_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0387-7604(96)00486-X","volume":"19","author":"T Takata","year":"1997","unstructured":"Takata, T., Okumiya, T., Hayashibe, H., Shimmoto, M., Kase, R., Itoh, K. et al. Screening and detection of gene mutations in Japanese patients with Fabry disease by non-radioactive single-stranded conformation polymorphism analysis. Brain Dev. 19, 111\u2013116 (1997).","journal-title":"Brain Dev."},{"key":"BFjhg201268_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/jhg.2010.5","volume":"55","author":"S Saito","year":"2010","unstructured":"Saito, S., Ohno, K., Sese, J., Sugawara, K., Sakuraba, H. Prediction of the clinical phenotype of Fabry disease based on protein sequential and structural information. J. Hum. Genet. 55, 175\u2013178 (2010).","journal-title":"J. Hum. Genet."},{"key":"BFjhg201268_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1536\/ihj.52.308","volume":"52","author":"N Nakagawa","year":"2011","unstructured":"Nakagawa, N., Maruyama, H., Ishihara, T., Seino, U., Kawabe, J., Takahashi, F. et al. Clinical and genetic investigation of a Japanese family with cardiac fabry disease. Identification of a novel alpha-galactosidase A missense mutation (G195V). Int. Heart J. 52, 308\u2013311 (2011).","journal-title":"Int. Heart J."},{"key":"BFjhg201268_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/jhg.2010.58","volume":"55","author":"BH Lee","year":"2010","unstructured":"Lee, B.H., Heo, S.H., Kim, G.H., Park, JY., Kim, W.S., Kang, D.H. et al. Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns. J. Hum. Genet. 55, 512\u2013517 (2010).","journal-title":"J. Hum. Genet."},{"key":"BFjhg201268_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle, P.J., Hopwood, J.J., Clague, A.E., Carey, W.F. Prevalence of Lysosomal Storage Disorders. JAMA 281, 249\u2013254 (1999).","journal-title":"JAMA"},{"key":"BFjhg201268_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s004399900075","volume":"105","author":"BJ Poorthuis","year":"1999","unstructured":"Poorthuis, B.J., Wevers, R.A., Kleijer, W.J., Groener, J.E., de Jong, J.G., van Weely, S. et al. The frequency of lysosomal storage diseases in The Netherlands. Hum. Genet. 105, 151\u2013156 (1999).","journal-title":"Hum. Genet."},{"key":"BFjhg201268_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada, M., Pagliardini, S., Yasuda, M., Tukel, T., Thiagarajan, G., Sakuraba, H. et al. High incidence of later-onset fabry disease revealed by newborn screening. Am. J. Hum. Genet. 79, 31\u201340 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg201268_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/humu.9520","volume":"29","author":"M Shimotori","year":"2008","unstructured":"Shimotori, M., Maruyama, H., Nakamura, G., Suyama, T., Sakamoto, F., Itoh, M. et al. Novel mutations of the GLA gene in Japanese patients with Fabry disease and their functional characterization by active site specific chaperone. Hum. Mutat. 29, 331 (2008).","journal-title":"Hum. Mutat."},{"key":"BFjhg201268_CR27","doi-asserted-by":"crossref","unstructured":"Togawa, T., Tsukimura, T., Kodama, T., Tanaka, T., Kawashima, I., Saito, S. et al. Fabry disease: biochemical, pathological and structural studies of the alpha-galactosidase A with E66Q amino acid substitution. Mol. Genet. Metab. (2012).","DOI":"10.1016\/j.ymgme.2012.01.010"},{"key":"BFjhg201268_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/jhg.2011.31","volume":"56","author":"S Saito","year":"2011","unstructured":"Saito, S., Ohno, K., Sakuraba, H. Fabry-database.org: database of the clinical phenotypes, genotypes and mutant alpha-galactosidase A structures in Fabry disease. J. Hum. Genet. 56, 467\u2013468 (2011).","journal-title":"J. Hum. Genet."},{"key":"BFjhg201268_CR29","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s10038-008-0316-9","volume":"53","author":"K Sugawara","year":"2008","unstructured":"Sugawara, K., Ohno, K., Saito, S., Sakuraba, H. Structural characterization of mutant alpha-galactosidases causing Fabry disease. J. Hum. Genet. 53, 812\u2013824 (2008).","journal-title":"J. Hum. Genet."},{"key":"BFjhg201268_CR30","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1681\/ASN.2006080816","volume":"18","author":"DP Germain","year":"2007","unstructured":"Germain, D.P., Waldek, S., Banikazemi, M., Bushinsky, D.A., Charrow, J., Desnick, R.J. et al. Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease. J. Am. Soc. Nephrol. 18, 1547\u20131557 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFjhg201268_CR31","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley, R.N., Parfrey, P.S., Sarnak, M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 32, S112\u2013S119 (1998).","journal-title":"Am. J. Kidney Dis."}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg201268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201268","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:30:49Z","timestamp":1684416649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg201268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,14]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["BFjhg201268"],"URL":"https:\/\/doi.org\/10.1038\/jhg.2012.68","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,14]]}}}